Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Continuous Glucose Monitoring Systems for Optimizing Glycemic Control in Patients With Newly Diagnosed Type 2 Diabetes: A Postmarketing Clinical Analysis

NCT07690163 is registered in ClinicalTrials.gov with Nazarii Kobyliak as lead sponsor.

NCT NCT07690163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07690163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Continuous Glucose Monitoring Systems for Optimizing Glycemic Control in Patients With Newly Diagnosed Type 2 Diabetes: A Postmarketing Clinical Analysis
Lead sponsor
Nazarii Kobyliak
Phase
Not applicable
Overall status
Recruiting
Start date
July 15, 2026
Completion date
March 31, 2027
Enrollment
80 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, obesity & overweight, obesity type 2 diabetes mellitus, type 2 diabetes (t2dm)